Inotuzumab ozogamicin View all treatment options
CD22 MAb ADC
Adapted from Thomas X. Profile of inotuzumab ozogamicin and its potential in the treatment of acute lymphoblastic leukemia. Blood and lymphatic cancer: targets and therapy. April 2014; 4: 1-8. doi: 10.2147/BLCTT.S49048
All content on this site is intended for healthcare professionals only. If you are a patient or carer, please visit the Lymphoma Coalition.